Profund Advisors LLC Palatin Technologies Inc Transaction History

Profund Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$0.67 - $1.01 $6,917 - $10,427	-10,324 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $2,521 - $4,002	-4,002 Reduced 27.94%	10,324 $7,000
Q2 2018 Aug 13, 2018	BUY	$0.91 - $1.45 $13,036 - $20,772	14,326 New	14,326 $14,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Profund Advisors LLC with notifications on news.